1)Griffith DE, Aksamit T, Brown-Elliott BA, et al : An official ATS/IDSA statement : diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care 175:367-416,2007
2)Namkoong H, Kurashima A, Morimoto K, et al : Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan. Emerg Infect Dis 22:1116-1117,2016
3)坂谷光則:非定型抗酸菌症.結核 80:25-30,2005
4)Gupta RS, Lo B, Son J : Phylogenomics and Comparative Genomic Studies Robustly Support Division of the Genus Mycobacterium into an Emended Genus Mycobacterium and Four Novel Genera. Front Microbiol 9:67,2018
5)Brown-Elliott BA, Philley JV : Rapidly Growing Mycobacteria. Microbiol Spectr 5:10,2017
6)Clinical Laboratory Standards Institute : M24 Susceptibility testing of Mycobacteria, Nocardia spp., and other aerobic Actinomyces, 3rd Ed. CLSI, Wayne, PA, 2018
7)日本結核病学会抗酸菌検査法検討委員会:抗酸菌検査ガイド2020.一般社団法人日本結核病学会,pp106-107,2020
8)Nash KA, Zhang Y, Brown-Elliott BA, et al : Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother 55:170-177,2005
9)Maurer FP, Castelberg C, Quiblier C, et al : Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus. J Antimicrob Chemother 69:1559-1563,2014
10)Mougari F, Bouziane F, Crockett F, et al : Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. Antimicrob Agents Chemother 61:e00943-16,2016